Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 67

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 67
---
, and claims, investigations and other proceedings by governmental authorities, relating to allegations that our business practices do not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations, and it is possible that courts or governmental authorities may conclude that we have not complied with them, or that we may find it necessary or appropriate to settle any such claims or other proceedings. In connection with any such claims, proceedings, or settlements, we may be subject to significant penalties, including civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government funded healthcare programs, such as Medicare and Medicaid, integrity oversight and reporting obligations, contractual damages, reputational harm, diminished profits and future earnings and the curtailment or restructuring of our operations. Defending against any such actions can be costly, time-consuming and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired. Further, if any of the physicians or other healthcare providers or entities with whom we expect to do business is found to be not in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs.

Our employees, contractors, collaborators, investigators, CROs, suppliers and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.

We face risks that employees, contractors, collaborators, investigators, CROs, suppliers, or vendors may engage in misconduct or improper activities, such as violating FDA regulations, healthcare fraud and abuse laws, or mishandling confidential information. Such actions could result in regulatory sanctions, reputational damage, significant penalties, exclusion from government healthcare programs, and other adverse impacts on our business and financial condition. Despite our code of conduct and compliance efforts, we may not always detect or prevent these risks, and any resulting investigations or legal actions could materially harm our operations and future prospects.

If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on our business.

We are subject to strict environmental, health, and safety laws regarding the handling, use, and disposal of hazardous materials. Our operations involve hazardous chemicals and biological materials, which pose risks of contamination, injury, and hazardous waste production. While we use third parties for disposal and hold workers’ compensation insurance, we lack insurance for